The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 10, 2015

Filed:

Aug. 23, 2013
Applicant:

Janssen Biotech, Inc., Horsham, PA (US);

Inventors:

Michael Naso, Spring House, PA (US);

T. Shantha Raju, Spring House, PA (US);

Bernard Scallon, Spring House, PA (US);

Assignee:

Janssen Biotech, Inc., Horsham, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12P 21/06 (2006.01); C12N 9/00 (2006.01); C12N 1/20 (2006.01); C12N 15/00 (2006.01); C07H 21/04 (2006.01); C07K 16/24 (2006.01); C07K 16/00 (2006.01); C12P 21/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/241 (2013.01); C07K 16/00 (2013.01); C07K 2317/41 (2013.01); C07K 2317/72 (2013.01); C07K 2317/732 (2013.01); C12P 21/005 (2013.01);
Abstract

The properties of an Fc-containing protein, for example, an antibody, are controlled by altering the sialylation of the oligosaccharides in the Fc region by transfecting the cell line expressing the Fc-containing protein with a vector sequence encoding a sialidase. The modified Fc-containing proteins have therapeutic utility in diseases or conditions in which it is desirable to control the affinity for one or more of the FcγRI, FcγRIIA, and FcγRIIIA receptors, ADCC activity, macrophage or monocyte activation, serum half-life, and avidity.


Find Patent Forward Citations

Loading…